BNET Industries

Perrigo Co.

(PRGO) is in the Pharma Industry

Market Cap:$3.5B
Last Fiscal Year Sales:$1.8B
  • Public
  • US
Dow Jones Description

Perrigo Company, established in 1887, is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the worlds largest manufacturer of OTC pharmaceutical products for the store brand market. The Companys primary markets and locations of manufacturing and logistics operations are the United States (U.S.), Israel, Mexico and the United Kingdom (U.K.). See Note 17 to the Companys consolidated financial statements for further information. Perrigo Company operates through several wholly owned subsidiaries. In the U.S., its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., Perrigo Holland, Inc. (formerly J.B. Laboratories, Inc.) and Perrigo Florida, Inc. (formerly Unico Holdings, Inc.). Outside the U.S., its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Brunel Pharma Limited (formerly Brunel Healthcare Ltd.) and Galpharm Healthcare Ltd. As used herein, references to the Company means Perrigo Company, its subsidiaries and all predecessors of Perrigo Company and its subsidiaries.

Number of Employees 6,200
Contact Information

515 Eastern Ave

Allegan, Michigan 49010-9070

perrigo.com

(269) 673-8451

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Perrigo a Go-Go

    11/03/09 - Financial Announcement - View Story

  • NPI Watch - Nov. 2, 2009 - Editorial: Dr. Joshua Sharfstein at the Annual...

    11/03/09 - Stock Split / Dividend - View Story

  • Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009

    10/19/09 - Financial Announcement - View Story

  • Bank of America Maintains a 'Buy' on Perrigo Company PRGO; Raises PT

    9/30/09 - Bond / Stock Rating - View Story

  • UPDATE 1-Perrigo buys KV Pharma filing for generic acne gel

    9/21/09 - Merger / Acquisition - View Story

  • BUYINS.NET: 50.78% Of All NASDAQ Trading Tuesday Was Short Selling. BPSG, SHAW, ELOS, EXEL, PRGO,...

    9/16/09 - Joint Venture / Alliance - View Story

  • Expansion anticipated as Perrigo enters new fiscal year

    8/30/09 - Financial Announcement - View Story

  • Perrigo gears up for cough/cold season

    8/20/09 - Product Announcement - View Story

  • Collins Stewart Reiterates a 'Buy' Rating on Perrigo PRGO; Raises Price Target

    8/19/09 - Bond / Stock Rating - View Story

  • Perrigo Company reports dividend of USD0.055 per share

    8/14/09 - Stock Split / Dividend - View Story

  • Perrigo posts $144M profit

    8/19/09 - Financial Announcement - View Story

  • Notable Analyst Rating Changes 5/21: TGT, FCX, CME, THC, CSIQ Upgraded; PETM, VALE, POT Downgraded

    5/21/09 - Bond / Stock Rating - View Story

News & Analysis

perrigo co. - All News and Analysis

advertisement
     PRGO $39.18 +0.44 (1.14% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 890,152
Shares Outstanding 91.33M
Market Cap 3.6B
Year High 39.19
Year Low 18.54
Earnings Per Share 1.51
P/E Ratio 25.95
Dividend 0.22
Yield 0.56
IndustryTop Rated
advertisement
Click Here